RhumbLine Advisers’s CASTLIGHT HEALTH, INC. CSLT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-112,045
| Closed | -$173K | – | 3030 |
|
|
2021
Q4 | $173K | Sell |
112,045
-888
| -0.8% | -$1.47K | ﹤0.01% | 2864 |
|
|
2021
Q3 | $177K | Buy |
112,933
+3,480
| +3% | +$6.82K | ﹤0.01% | 2928 |
|
|
2021
Q2 | $288K | Buy |
+109,453
| New | +$204K | ﹤0.01% | 2806 |
|
|
2020
Q2 | – | Sell |
-116,458
| Closed | -$84K | – | 3145 |
|
|
2020
Q1 | $84K | Hold |
116,458
| – | – | ﹤0.01% | 2809 |
|
|
2019
Q4 | $155K | Buy |
116,458
+1,314
| +1% | +$1.83K | ﹤0.01% | 2808 |
|
|
2019
Q3 | $162K | Sell |
115,144
-775
| -0.7% | -$1.54K | ﹤0.01% | 2798 |
|
|
2019
Q2 | $374K | Buy |
115,919
+19,171
| +20% | +$66K | ﹤0.01% | 2493 |
|
|
2019
Q1 | $363K | Sell |
96,748
-3,098
| -3% | -$9.84K | ﹤0.01% | 2455 |
|
|
2018
Q4 | $217K | Buy |
99,846
+34,199
| +52% | +$84.8K | ﹤0.01% | 2701 |
|
|
2018
Q3 | $177K | Sell |
65,647
-4,275
| -6% | -$15.1K | ﹤0.01% | 2766 |
|
|
2018
Q2 | $297K | Buy |
69,922
+16,520
| +31% | +$62.1K | ﹤0.01% | 2538 |
|
|
2018
Q1 | $195K | Sell |
53,402
-2,000
| -4% | -$7.42K | ﹤0.01% | 2613 |
|
|
2017
Q4 | $208K | Sell |
55,402
-11,432
| -17% | -$45.8K | ﹤0.01% | 2614 |
|
|
2017
Q3 | $287K | Buy |
66,834
+930
| +1% | +$3.83K | ﹤0.01% | 2573 |
|
|
2017
Q2 | $274K | Buy |
65,904
+23,170
| +54% | +$90.3K | ﹤0.01% | 2605 |
|
|
2017
Q1 | $156K | Buy |
42,734
+1,891
| +5% | +$6.64K | ﹤0.01% | 2712 |
|
|
2016
Q4 | $202K | Buy |
40,843
+8,756
| +27% | +$39.7K | ﹤0.01% | 2670 |
|
|
2016
Q3 | $133K | Buy |
32,087
+650
| +2% | +$2.65K | ﹤0.01% | 2770 |
|
|
2016
Q2 | $124K | Sell |
31,437
-735
| -2% | -$2.88K | ﹤0.01% | 2883 |
|
|
2016
Q1 | $107K | Hold |
32,172
| – | – | ﹤0.01% | 2881 |
|
|
2015
Q4 | $137K | Buy |
32,172
+3,015
| +10% | +$13K | ﹤0.01% | 2901 |
|
|
2015
Q3 | $122K | Buy |
29,157
+1,122
| +4% | +$7.08K | ﹤0.01% | 2913 |
|
|
2015
Q2 | $228K | Buy |
28,035
+14,995
| +115% | +$125K | ﹤0.01% | 2816 |
|
|
2015
Q1 | $101K | Buy |
13,040
+2,200
| +20% | +$18.8K | ﹤0.01% | 2952 |
|
|
2014
Q4 | $127K | Buy |
10,840
+600
| +6% | +$7.16K | ﹤0.01% | 2930 |
|
|
2014
Q3 | $133K | Hold |
10,240
| – | – | ﹤0.01% | 2884 |
|
|
2014
Q2 | $156K | Buy |
+10,240
| New | +$166K | ﹤0.01% | 2918 |
|
RhumbLine Advisers's CSLT Position: Q1 2022 in Review
RhumbLine Advisers sold out of CASTLIGHT HEALTH, INC. (CSLT) in Q1 2022, closing a stake of 112,045 shares — an estimated $173K sold.
RhumbLine Advisers first reported a position in CSLT in Q2 2014 and held it in 27 quarters. The position peaked at $374K in Q2 2019. 0 funds tracked by Wall St. Rank hold CSLT as of Q1 2022.
- RhumbLine Advisers reported no remaining CASTLIGHT HEALTH, INC. position as of Q1 2022 after selling out during the quarter.
- RhumbLine Advisers sold 112,045 CASTLIGHT HEALTH, INC. shares in Q1 2022, an estimated $173K.
- RhumbLine Advisers first reported a position in CASTLIGHT HEALTH, INC. in Q2 2014 and held it in 27 quarters.
- RhumbLine Advisers's CASTLIGHT HEALTH, INC. position peaked at $374K in Q2 2019.
- 0 funds tracked by Wall St. Rank held CASTLIGHT HEALTH, INC. as of Q1 2022.
Based on RhumbLine Advisers's 13F filing for Q1 2022, filed 12 May 2022.